No apparent differences were detected in the cellular homogeneity or viability of fibroblasts derived from tumour or proximal breast tissues that might explain the marked differences in basal and IL-6+IL-6sR-stimulated aromatase activity in these different fibroblasts. This evidence concerns the gene IL6 and neoplasm.